Latest / Cleveland Clinic Cancer Advances
IsoPSA Test
Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute joins the Cancer Advances podcast to discuss the IsoPSA Test, now being offered at Cleveland Clinic. The IsoPSA test is a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy. Listen as Dr. Klein discusses how the IsoPSA test differs from conventional PSA testing and how your patients can benefit.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.